GL1X · GenesisL1 explorer

Ligand · CQG

CQG · pyridin-4-ol

CQG, pyridin-4-ol (C5 H5 N O, 95.1 g/mol), in the MolNFT structures on GenesisL1: bound in 9 records (7 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.

Component
CQG
Formula
C5 H5 N O
Class
ligand
Structures
9
PDB entries
7

Binding sites

CQG in 9 structures; the first of them:

  • 6MME · Citrobacter freundii tyrosine phenol-lyase complexed with 4-hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
  • 6NV8 · Perdeuterated tyrosine phenol-lyase from Citrobacter freundii complexed with an… · CQG A1002 · binds GLU227, GLN228, ARG323
  • 6B4Q · Crystal structure of purine nucleoside phosphorylase isoform 2 from schistosoma mansoni… · CQG A307 · binds LEU118, ALA119, GLY120, TYR202, GLU203, VAL219, GLY220, MET221 and 1 more
  • 6MLS · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
  • 6MME · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
  • 6MO3 · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A1601 · binds GLU227, GLN228, ARG323
  • 6MPD · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A1002 · binds GLN228, ARG323
  • 6MQQ · Citrobacter freundii F448A mutant tyrosine phenol-lyase complexed with 4-hydroxypyridine… · CQG A601 · binds PHE123, THR124, ARG381, PHE449, 0JO603, TYR71
  • 6NV8 · Perdeuterated tyrosine phenol-lyase from citrobacter freundii complexed with an… · CQG A1002 · binds GLU227, GLN228, ARG323

Residues it binds most

ARG 16, PHE 8, THR 15, GLU 11, TYR 10, SER 7, 0JO 8, VAL 8, ASP 7, GLN 7 (residue and the binding sites it lines).

Found with

  • K · Potassium ion
  • P33 · 3,6,9,12,15,18-hexaoxaicosane-1,20-diol
  • DMS · Dimethyl sulfoxide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.